-
CEPI to help advance development and manufacture of COVID-19 vaccine from Biological E
expresspharma
December 30, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) and Biological E, India announced a collaboration to advance the development and manufacture of Biological E’s COVID-19 subunit vaccine candidate.
-
Novavax announces initiation of PREVENT-19 pivotal Phase 3 efficacy trial of COVID-19 vaccine in the United States and Mexico
worldpharmanews
December 29, 2020
Novavax, Inc. announced initiation of PREVENT-19, its pivotal Phase 3 study in the United States and Mexico to evaluate the efficacy, safety and immunogenicity of NVX-CoV2373, the Company's COVID-19 vaccine candidate.
-
Russia approves Sputnik V Covid-19 vaccine for senior citizens
pharmaceutical-technology
December 29, 2020
The Russian government has approved its Covid-19 vaccine, Sputnik V, for use by individuals aged 60 years and above.
-
COVAXX, Aurobindo sign Covid-19 vaccine development deal
pharmaceutical-technology
December 29, 2020
US company COVAXX has signed an exclusive agreement with Indian company Aurobindo Pharma to expand global development and commercialisation of the former’s multitope peptide-based Covid-19 vaccine, UB-612, to India and the United Nations Children’s Fund.
-
US doctor develops severe allergic reaction to Moderna COVID-19 vaccine, reports NYT
expresspharma
December 28, 2020
It is the first severe reaction publicly linked to Moderna’s vaccine, which is in its first week of rollout in the US.
-
India has key role to play in equitable distribution of COVID-19 vaccines: Industry experts
expresspharma
December 28, 2020
With vaccine rollout beginning in some countries, the world ravaged by the COVID-19 pandemic is looking to India for the large-scale production and supply of coronavirus vaccines as it enters 2021.
-
Moderna’s Covid-19 vaccine obtains Health Canada authorisation
pharmaceutical-technology
December 25, 2020
Moderna has received authorisation for its Covid-19 vaccine from Health Canada for the immunisation of individuals aged 18 years and above.
-
Argentina registers Russia’s Covid-19 vaccine Sputnik V
pharmaceutical-technology
December 25, 2020
The Russian Direct Investment Fund (RDIF) has announced that the National Administration of Drugs, Foods and Medical Devices of Argentina (ANMAT) has registered the Sputnik V vaccine against Covid-19.
-
Aurobindo Pharma to make COVAXX’s potential COVID-19 vaccine for India, UNICEF
expresspharma
December 25, 2020
Currently, Aurobindo can produce 220 million doses, but is ramping up its facilities to reach a capacity of nearly 480 million by June 2021.
-
Moderna expects its COVID-19 vaccine to protect against UK coronavirus variant
expresspharma
December 25, 2020
Moderna said it expects that the immunity induced by its COVID-19 vaccine would be protective against the coronavirus variants reported in the UK.